Publication | Open Access
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
19
Citations
48
References
2022
Year
A unique FOXA1-ER axis in invasive lobular breast cancer promotes disease progression and tamoxifen resistance, highlighting a potential therapeutic avenue for clinical investigations dedicated to this disease. See related commentary by Blawski and Toska, p. 3668.
| Year | Citations | |
|---|---|---|
2013 | 13.2K | |
2012 | 12.1K | |
2012 | 6.2K | |
2013 | 4.2K | |
2015 | 1.9K | |
2000 | 1.7K | |
2005 | 1.4K | |
2018 | 1.3K | |
2002 | 1.1K | |
2004 | 855 |
Page 1
Page 1